FindTrial
Sign In

Standardized diagnosis and treatment and application of non / minimally invasive screening methods of gynecological tumors during pregnancy

Standardized diagnosis and treatment and application of non / minimally invasive screening methods of gynecological tumors during pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056855
Enrollment
Unknown
Registered
2022-02-20
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecological tumors during pregnancy

Interventions

Gold Standard:pathologic diagnosis after operation
Index test:DNA methylation detection

Sponsors

International Peace Maternity and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients with gynecological tumors or precancerous lesions (cervical cancer, ovarian cancer, fallopian tube cancer, etc.) found and diagnosed during pregnancy or highly suspected; 2. Plan to be treated and followed up in our hospital or cooperative hospitals; 3. Aged 20-45 years; 4. Have fertility requirements.

Exclusion criteria

Exclusion criteria: 1. Termination of pregnancy in the first trimester; 2. Combined with other systemic malignancies; 3. Previous history of gynecologic malignancy, including after treatment.

Design outcomes

Primary

MeasureTime frame
DNA methylation level;Tumor markers;—

Countries

China

Contacts

Public ContactWang Yudong

International Peace Maternity and Child Health Hospital

owangyudong@126.com+86 18017316053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026